MAPT and supranuclear palsy, progressive, 1: Previous correlative results between tau-PET tracer binding and PSP disease severity have been inconsistent, showing no7 or positive association.8,25 Especially for 18F-THK5351, this could be explained by increased monoaminoxidase-B expression in this disorder as a neuroinflammation event.